SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950152-04-008730
Filing Date
2004-12-03
Accepted
2004-12-02 21:59:22
Documents
9
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 MYLAN LABORATORIES, INC. j1082801e10vqza.txt 10-Q/A 10370
2 EXHIBIT 10.27 j1082801exv10w27.txt EX-10.27 27681
3 EXHIBIT 10.28 j1082801exv10w28.txt EX-10.28 30020
4 EXHIBIT 10.29 j1082801exv10w29.txt EX-10.29 30006
5 EXHIBIT 10.30 j1082801exv10w30.txt EX-10.30 29477
6 EXHIBIT 10.31 j1082801exv10w31.txt EX-10.31 25066
7 EXHIBIT 31.1 j1082801exv31w1.txt EX-31.1 3386
8 EXHIBIT 31.2 j1082801exv31w2.txt EX-31.2 3390
9 EXHIBIT 32 j1082801exv32.txt EX-32 2088
  Complete submission text file 0000950152-04-008730.txt   164109
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317 724-514-1800
MYLAN LABORATORIES INC (Filer) CIK: 0000069499 (see all company filings)

IRS No.: 251211621 | State of Incorp.: PA | Fiscal Year End: 0331
Type: 10-Q/A | Act: 34 | File No.: 001-09114 | Film No.: 041181991
SIC: 2834 Pharmaceutical Preparations